Integral Diagnostics (ASX:IDX) logged AU$0.126 in operating earnings per share for fiscal 2026, compared with AU$0.102 a year ago, a Tuesday filing showed.
For the 12 months ended June 30, revenue was AU$788.6 million versus AU$627.2 million previously, the Australia-listed healthcare company added.
The board declared a final dividend of AU$0.06 per share, up from AU$0.04 a year earlier, payable Oct. 2 to shareholders on record as of Aug. 31.
The company expects fiscal 2027 replacement and growth capital expenditures of AU$50 million to AU$60 million.